Who owns PLIANT THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of PLRX from SEC Form 13F filings across 56 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 56 institutions disclosed 22.8M shares of PLIANT THERAPEUTICS, INC. worth $22.6M — about 36.8% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
56
13F holders
$22.6M
value, 2026 filers
36.8%
of shares outstanding (22.8M sh)
5
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of PLRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | $2.8M | 0.0% | 3.9% | -47.9% |
| 2 | ACADIAN ASSET MANAGEMENT LLC | 2.4M | $2,747 | 0.0% | 3.9% | 0.0% |
| 3 | TWO SIGMA INVESTMENTS, LP | 2.3M | $2.6M | 0.0% | 3.7% | +0.4% |
| 4 | CITADEL ADVISORS LLC | 2.1M | $2.4M | 0.0% | 3.5% | -33.6% |
| 5 | Monaco Asset Management SAM | 1.9M | $2.2M | 0.2% | 3.1% | 0.0% |
| 6 | Prosight Management, LP | 1.4M | $1.6M | 0.3% | 2.2% | -17.8% |
| 7 | Woodline Partners LP | 1.3M | $1.5M | 0.0% | 2.1% | -61.1% |
| 8 | BlackRock, Inc. | 1.2M | $1.3M | 0.0% | 1.9% | +5.0% |
| 9 | MARSHALL WACE, LLP | 835,124 | $952,041 | 0.0% | 1.3% | -16.1% |
| 10 | JPMORGAN CHASE & CO | 681,647 | $783,894 | 0.0% | 1.1% | -20.9% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 578,577 | $659,954 | 0.0% | 0.9% | +38.7% |
| 12 | UBS Group AG | 571,760 | $651,806 | 0.0% | 0.9% | -46.0% |
| 13 | MILLENNIUM MANAGEMENT LLC | 559,447 | $637,770 | 0.0% | 0.9% | -52.6% |
| 14 | Connor, Clark & Lunn Investment Management Ltd. | 536,081 | $611,132 | 0.0% | 0.9% | +3.6% |
| 15 | BESSEMER GROUP INC | 532,079 | $606 | 0.0% | 0.9% | 0.0% |
| 16 | Laurion Capital Management LP | 412,796 | $470,587 | 0.0% | 0.7% | 0.0% |
| 17 | TORNO CAPITAL, LLC | 351,445 | $400,647 | 0.0% | 0.6% | +0.4% |
| 18 | VANGUARD FIDUCIARY TRUST CO | 341,751 | $389,596 | 0.0% | 0.6% | +0.7% |
| 19 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 303,000 | $345,420 | 0.0% | 0.5% | new |
| 20 | MORGAN STANLEY | 298,976 | $340,833 | 0.0% | 0.5% | -40.9% |
| 21 | SEI INVESTMENTS CO | 297,291 | $338,909 | 0.0% | 0.5% | 0.0% |
| 22 | GOLDMAN SACHS GROUP INC | 208,585 | $237,787 | 0.0% | 0.3% | -65.1% |
| 23 | Marquette Asset Management, LLCNEW | 174,500 | $198,930 | 0.0% | 0.3% | new |
| 24 | HighMark Wealth Management LLC | 166,224 | $189,495 | 0.1% | 0.3% | 0.0% |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | 153,712 | $175,232 | 0.0% | 0.2% | -0.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.